Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | SY-2101 |
Synonyms | |
Therapy Description |
Limited information is currently available on SY-2101, a putative form of Arsenic Trioxide (Apr 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SY-2101 | SY 2101|SY2101 | Limited information is currently available on SY-2101, a putative form of Arsenic Trioxide (Apr 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04996030 | Phase I | Arsenic trioxide + SY-2101 SY-2101 Arsenic trioxide | A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia | Suspended | USA | 0 |